top of page
Home
About Us
Disease Targets
Pipeline
Publications
News
Contact
Pipeline
Home
Next
Pipeline
Program
Exploratory
Discovery
Pre-Clinical
GMP/GLP/IND
Phase I/II
Clinical Trial
CRYBA1 GENE THERAPY
LIPOCALIN-2 ANTIBODY THERAPY
UNDISCLOSED TARGETS FOR AMD AND OTHER NEURODEGENER
A-TIVE AND RETINAL DISEASE THERAPY
bottom of page